Queen’s University

Queen’s University is a driver of innovation and talent based on excellence. The University is globally connected and networked with strategic partnerships across the world, helping it to expand its impact on wider society locally, nationally and globally.

The University is a leader in commercial impact, ranking in the top five UK universities for revenue generated from research commercialisation – £71m. Through its commercial arm, Queen’s has created over 70 spin-out companies. Three of these companies (Kainos, Andor Technology and Fusion Antibodies) have been publicly listed on the London Stock Exchange.

Throughout the University, leading research academics are collaborating across disciplines and with outside agencies and institutions on projects of world significance.